A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache

Completed

• Conditions: Headache; Migraine Disorders
• Interventions: Other: No Intervention

• Registration Number: NCT01946126
• Lead Sponsor: Allergan

Brief Summary

This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-09-17
• Study First Submitted QC: 2013-09-18
• Study First Posted: 2013-09-19
• Study Start: 2014-03
• Primary Completion: 2014-04
• Study Completion: 2014-04
• Results First Submitted: 2015-10-29
• Status Verified: 2016-02
• Results First Submitted QC: 2016-02-15
• Last Update Submitted: 2016-02-15
• Results First Posted: 2016-03-15
• Last Update Posted: 2016-03-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 459

Inclusion Criteria

• Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
• Eight (8) headache days per month for at least 1 of the preceding 15 months

Exclusion Criteria

• Not currently diagnosed with chronic migraine, headache or migraine
• History of receiving botulinum toxin injections for the treatment of chronic migraine.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Chronic Migraine Diagnosis	No Intervention	This is a retrospective chart review for patients diagnosed with Chronic Migraine. There is no intervention in this study.
Other Headache Diagnoses	No Intervention	This is a retrospective chart review of patients with headache diagnoses other than Chronic Migraine. There is no intervention in this study.

Primary Outcome Measures

Name	Time	Method
Presence or Absence of Prophylactic Medication for Headache/Migraine	15 Months	The presence or absence of prophylactic medications used by the subject for headache/migraine is evaluated through the study period.

Secondary Outcome Measures

Name	Time	Method
Number of Visits for Headache Diagnosis	15 Months	The number of visits for headache diagnosis is evaluated through the study period.
Highest Number of Headache Days Per Month at a Qualifying Visit	15 Months	The highest number of headache days per month are reported at a qualifying visit per the medical record.
Number of Unique Prophylactic Medications for Headache/Migraine Reported	15 Months	The numbers of unique prophylactic medications used by the subjects for headache/migraine are evaluated through the study period.
Number of Days With a Headache Recorded at the Visit With the Highest Number of Headaches	15 Months	The number of headache days is reported at the visit with the highest number of headaches.